Skip to main content
SpringerLink
Log in

Overview of Disease Management Approaches

Implications for Corporate-Sponsored Programs

  • Review Article
  • Published:
Disease Management & Health Outcomes

Abstract

Corporations have engaged in sponsorship of health management programs and, more recently, disease management programs to facilitate healthy and productive work environments. The purpose of this review is to examine the health and financial outcomes from these corporate-sponsored disease management programs. This article focuses on seven diseases or chronic conditions (arthritis, asthma, cancer, depression, diabetes mellitus, heart disease, and migraine) that potentially impact employee productivity (both in time away from work and in loss of effectiveness at work) and health status including medical and pharmaceutical utilization and costs.

Corporate-sponsored disease management programs typically focus on education and screening for selected diseases or chronic conditions. Partnerships have been formed with health plans and third-party program providers to reach employees with interventions and treatment. The typical outcome measures from these programs have primarily been clinical indicators and medical utilization. Measures of productivity need to be incorporated as important outcome measures for disease management programs.

The estimated financial opportunity for the corporation is a reflection of the cost differential for a given disease and the prevalence of that disease within the employee population. Primary diseases, chronic conditions, and health risks contribute to increased medical utilization and decreased productivity within the corporation. Promoting programs that focus on the whole person, including health risks, chronic conditions, and diseases, will likely increase the possibility of success in helping the employee to better self-manage their health conditions and consequently provide gains for both the individual and the corporation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Table II
Fig. 2
Fig. 3
Table III
Table IV

Similar content being viewed by others

References

  1. Bloom DE, Canning D. The health and wealth of nations. Science 2000; 287: 1207–9

    Article  PubMed  CAS  Google Scholar 

  2. Pelletier KR. A review and analysis of the clinical and cost-effectiveness studies of comprehensive health promotion and disease management programs at the worksite: 1995–1998 update. Am J Health Promot 1999; 13: 333–45

    Article  PubMed  CAS  Google Scholar 

  3. Heaney CA, Goetzel RZ. A review of health-related outcomes of multi-component worksite health promotion programs. Am J Health Promot 1997; 11: 290–307

    Article  PubMed  CAS  Google Scholar 

  4. Aldana SG. Financial impact of health promotion programs: a comprehensive review of the literature. Am J Health Promot 2001; 15: 296–320

    Article  PubMed  CAS  Google Scholar 

  5. Burton WN, Conti DJ, Chen CY, et al. The role of health risk factors and disease on worker productivity. J Occup Environ Med 1999; 41: 863–77

    Article  PubMed  CAS  Google Scholar 

  6. Musich SA, Napier D, Edington DW. The association of health risks with workers’ compensation costs. J Occup Environ Med 2001; 43: 534–41

    Article  PubMed  CAS  Google Scholar 

  7. Schultz AB, Lu CF, Barnett TR, et al. Influence of participation in a worksite health promotion program on disability days. J Occup Environ Med 2002; 44: 776–80

    PubMed  Google Scholar 

  8. Edington DW, Yen L, Witting P. The financial impact of changes in personal health practices. J Occup Environ Med 1997; 39: 1037–46

    Article  PubMed  CAS  Google Scholar 

  9. Lerner D, Reed JI, Massarotti E, et al. The work limitations questionnaire’s validity and reliability among patients with Osteoarthritis. J Clin Epidemiol 2002; 55: 197–208

    Article  PubMed  Google Scholar 

  10. Edington DW. Emerging research: a view from one research center. Am J Health Promot 2001; 15: 341–9

    Article  PubMed  CAS  Google Scholar 

  11. Lerner D, Amick BC, Lee JC, et al. Relationship of employee-reported work limitations to work productivity. Med Care 2003; 42: 649–59

    Google Scholar 

  12. Musich SA, Burton WN, Edington DW. Costs and benefits of prevention and disease management. Dis Manag Health Outcomes 1999; 5: 153–66

    Article  Google Scholar 

  13. Riedel JE, Lynch W, Baase C, et al. The effect of disease prevention and health promotion on workplace productivity: a literature review. Am J Health Promot 2001; 15: 167–91

    Article  PubMed  CAS  Google Scholar 

  14. Kessler RC, Greenberg PE, Mickelson KD, et al. The effects of chronic medical conditions on work loss and work cutback. J Occup Environ Med 2001; 43: 218–25

    Article  PubMed  CAS  Google Scholar 

  15. Wright DW, Beard MJ, Edington DW. The association of health risks with the cost of time away from work. J Occup Environ Med 2002; 44: 1126–34

    Article  PubMed  Google Scholar 

  16. Edington DW, Burton WN. Health and productivity. In: McCunney RJ, editor. A practical approach to occupational and environmental medicine. 3rd ed. Boston (MA): Little, Brown and Company, 2003: 140–52

    Google Scholar 

  17. Goetzel RZ, Ozminkowski RJ. Disease management as a part of total health and productivity management. Dis Manag Health Outcomes 2000; 8: 121–8

    Article  Google Scholar 

  18. Musich SA, Hirschland D, McDonald T, et al. Excess healthcare costs associated with excess health risks in disease and non-diseased health risk appraisal participants. Dis Manag Health Outcomes 2002; 10: 251–8

    Article  Google Scholar 

  19. Hook D, Musich SA, Edington DW. Excess healthcare costs associated with excess health risks among diseased and non-diseased health risk appraisal participants in an Australian health plan. Healthcover 2002; 18: 57–65

    Google Scholar 

  20. O’Connell JM, Kauffman LD. A framework for disease management ROI studies: a health-plan perspective. Dis Manag 2002; 5: 109–21

    Article  Google Scholar 

  21. Nash DB. Disease management: what does the research evidence show? Drug Benefit Trends 2002; 14: 18–24

    Google Scholar 

  22. Burton WN, Morrison A, Wertheimer AI. Pharmaceuticals and worker productivity loss: a critical review of the literature. J Occup Environ Med 2003; 45: 610–21

    Article  PubMed  Google Scholar 

  23. Amick BC, Lerner MS, Rogers WH, et al. A review of health-related work outcome measures and their uses, and recommended measures. Spine 2000; 25: 3152–60

    Article  PubMed  Google Scholar 

  24. Lawrence RC, Heimick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorder in the United States. Arthritis Rheum 1998; 41: 778–99

    Article  PubMed  CAS  Google Scholar 

  25. Muchmore L, Lynch WD, Gardner HH, et al. Prevalence of arthritis and associated joint disorders in an employed population and the associated healthcare, sick leave, disability, and workers’ compensation benefits cost and productivity loss for employers. J Occup Environ Med 2003; 45: 369–78

    Article  PubMed  Google Scholar 

  26. Hootman JM, Sniezek JE, Heimick CG. Women and arthritis: burden, impact and prevention programs. J Womens Health Gend Based Med 2002, 416

  27. Birnbaum HG, Aarton M, Greenberg PE, et al. Direct and indirect costs of rheumatoid arthritis to an employer. J Occup Environ Med 2000; 42: 588–96

    Article  PubMed  CAS  Google Scholar 

  28. Young A, Dixey J, Kulinsksya E, et al. Which patients stop working because of rheumatoid arthritis: results of five years’ follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis 2002; 61: 335–40

    Article  PubMed  CAS  Google Scholar 

  29. Shanahan EM, Smith MD. Rheumatoid arthritis, disability and the workplace. Best Pract Res Clin Rheumatol 1999; 13: 675–88

    Article  CAS  Google Scholar 

  30. Rasch EK, Hirsch R, Paulose-Ram R, et al. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States. Arthritis Rheum 2003; 48: 917–26

    Article  PubMed  Google Scholar 

  31. Barbour JA, Ginding J, Bridges M, et al. Evaluation of a screening tool for inflammatory joint disease. Ann Rheum Dis 2003; 62: 187–8

    Article  PubMed  CAS  Google Scholar 

  32. LaValley M, McAlindon TE, Evans S, et al. Problems in the development and validation of questionnaire-based screening instruments for ascertaining cases with symptomatic knee Osteoarthritis. Arthritis Rheum 2001; 44: 1105–13

    Article  PubMed  CAS  Google Scholar 

  33. Saraux A, Berthelot JM, Chales G, et al. Value of laboratory tests in early prediction of rheumatoid arthritis. Arthritis Rheum 2002; 47: 155–65

    Article  PubMed  Google Scholar 

  34. Visser H, le Cessie S, Vos K, et al. How to diagnose rheumatoid arthritis early: a predictive model for persistent (erosive) arthritis. Arthritis Rheum 2002; 46: 357–65

    Article  PubMed  Google Scholar 

  35. Warashina H, Hasegawa Y, Tsuchiya H, et al. Clinical, radiographic, and thermographic assessment of Osteoarthritis in the knee joints. Ann Rheum Dis 2002; 61: 852–4

    Article  PubMed  CAS  Google Scholar 

  36. Scott DL. The diagnosis and prognosis of early arthritis: rationale for new prognostic criteria. Arthritis Rheum 2002; 46: 286–90

    Article  PubMed  Google Scholar 

  37. Kim JM, Weisman MH. When does rheumatoid arthritis begin and why do we need to know. Arthritis Rheum 2000; 43: 473–84

    Article  PubMed  CAS  Google Scholar 

  38. O’Dell JR. Treating rheumatoid arthritis early: a window of opportunity? Arthritis Rheum 2002; 46: 283–5

    Article  PubMed  Google Scholar 

  39. Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs. Arthritis Rheum 1993; 36: 439–46

    Article  PubMed  CAS  Google Scholar 

  40. Superio-Cabuslay E, Ward MM, Lorig KR. Patient education interventions in Osteoarthritis and rheumatoid arthritis: a meta-analytic comparison with nonsteroidal anti-inflammatory drug treatment. Arthritis Care Res 1996; 9: 292–301

    Article  PubMed  CAS  Google Scholar 

  41. O’Grady M, Fletcher J, Ortiz S. Therapeutic and physical fitness exercise prescription for older adults with joint disease: an evidence-based approach. Rheum Dis Clin North Am 2000; 26: 617–46

    Article  PubMed  Google Scholar 

  42. Minor MA. Exercise in the treatment of Osteoarthritis. Rheum Dis Clin North Am 1999; 25: 397–415

    Article  PubMed  CAS  Google Scholar 

  43. Yocum DE, Castro WL, Cornett M. Exercise, education, and behavioral modification as alternative therapy for pain and stress in rheumatic disease. Rheum Dis Clin North Am 2000; 26: 145–59

    Article  PubMed  CAS  Google Scholar 

  44. van Baar ME, Dekker J, Oostendorp RAB, et al. Effectiveness of exercise in patients with Osteoarthritis of hip or knee: nine months’ follow up. Ann Rheum Dis 2001; 60: 1123–30

    Article  PubMed  Google Scholar 

  45. Felson DT, Lawrence RC, Hochberg MC, et al. Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med 2000; 133: 726–37

    PubMed  CAS  Google Scholar 

  46. Surveillance for asthma: United States, 1980–1999. Morb Mortal Wkly Rep Surveill Summ 2002; 51: 1–13

  47. Vollmer WM, Osborne ML, Buist AS. 20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. Am J Respir Crit Care Med 1998; 157: 1079–84

    PubMed  CAS  Google Scholar 

  48. Erickson SR, Kirking DM. A cross-sectional analysis of work-related outcomes in adults with asthma. Ann Allergy Asthma Immunol 2002; 88: 292–300

    Article  PubMed  Google Scholar 

  49. Blanc PD, Trupin L, Eisner M, et al. The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol 2001; 54: 610–8

    Article  PubMed  CAS  Google Scholar 

  50. Weiss KB, Gergen PJ, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992; 326: 862–3

    Article  PubMed  CAS  Google Scholar 

  51. Kowalski AF. Reducing asthma morbidity and mortality: cost containment strategies. AAOHN J 2000; 48: 418–22

    PubMed  CAS  Google Scholar 

  52. Smith DH, Malone DC, Lawson KA, et al. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997; 156: 787–93

    PubMed  CAS  Google Scholar 

  53. Vollmer WM, Markson LE, O’Connor E, et al. Association of asthma control with health care utilization. Am J Respir Crit Care Med 2002; 165: 195–9

    PubMed  Google Scholar 

  54. Van Graafeiland B. National asthma education and prevention program. Nurse Pract 2002; Suppl.: 7–12

  55. Vollmer WM, Markson LE, O’Connor E, et al. Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med 1999; 160: 1647–52

    PubMed  CAS  Google Scholar 

  56. Osborne ML, Vollmer WM, Linton KL, et al. Characteristics of patients with asthma within a large HMO. Am J Respir Crit Care Med 1998; 157: 123–8

    PubMed  CAS  Google Scholar 

  57. Osborne ML, Vollmer WM, Johnson RE, et al. Use of an automated prescription database to identify individuals with asthma. J Clin Epidemiol 1995; 48: 1393–7

    Article  PubMed  CAS  Google Scholar 

  58. Burton WN, Connerty CM, Schultz AB, et al. Bank One’s worksite-based asthma disease management program. J Occup Environ Med 2001; 43: 75–82

    Article  PubMed  CAS  Google Scholar 

  59. Boulet LP, Thivierge RL, Amesse A, et al. Towards excellence in asthma management (TEAM): a populational disease-management model. J Asthma 2002; 39: 341–50

    Article  PubMed  Google Scholar 

  60. Legorreta AP, Leung KM, Berkbigler D, et al. Outcomes of a population-based asthma management program: quality of life, absenteeism and utilization. Ann Allergy Asthma Immunol 2000; 85: 28–34

    Article  PubMed  CAS  Google Scholar 

  61. Baren JM, Shofer FS, Ivey B, et al. A randomized, controlled trial of a simple emergency department intervention to improve the rate of primary care follow-up for patients with acute asthma exacerbations. Ann Emerg Med 2001; 38: 115–22

    Article  PubMed  CAS  Google Scholar 

  62. Ignacio-Garcia JM, Pinto-Tenorio M, Chocron-Giraldez MJ, et al. Benefits at 3 yrs of an asthma education programme coupled with regular reinforcement. Eur Respir J 2002; 20: 1095–101

    Article  PubMed  CAS  Google Scholar 

  63. Gallefoss F, Bakke PS. Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respir Med 2000; 94: 279–87

    Article  PubMed  CAS  Google Scholar 

  64. Buchner DA, Butt LT, De Stefano A, et al. Effects of an asthma management program on the asthmatic member: patient-center results of a 2-year study in a managed care organization. Am J Manag Care 1998; 4: 1288–97

    PubMed  CAS  Google Scholar 

  65. Cote J, Cartier A, Robichaud P, et al. Influence on asthma morbidity of asthma education programs based on self-management plans following treatment optimization. Am J Respir Crit Care Med 1997; 155: 1509–14

    PubMed  CAS  Google Scholar 

  66. Lucas DO, Zimmer LO, Paul JE, et al. Two-year results from the asthma self-management program: long-term impact on health care services, costs, functional status, and productivity. J Asthma 2001; 38: 321–30

    Article  PubMed  CAS  Google Scholar 

  67. Gillespie JL. The value of disease management: part 3. balancing cost and quality in the treatment of asthma. Dis Manag 2002; 8: 225–32

    Article  Google Scholar 

  68. Marks GM, Jalaludin BB, Williamson M, et al. Use of “preventer” medications and written asthma management plan among adults with asthma in New South Wales. Med J Aust 2000; 173: 407–10

    PubMed  CAS  Google Scholar 

  69. Adams PF, Marano MA. Current estimates from the National Health Interview, 1994. Vital Health Stat 10 1995; 193: 81–108

    Google Scholar 

  70. Burton WN, Schultz AB, Connerty CM, et al. Asthma disease management: a worksite-based asthma education program. Dis Manag 2001; 4: 3–13

    Article  Google Scholar 

  71. American Cancer Society. Cancer facts & figures 2004 [online]. Available at URL: http://www.cancer.org/downloads/STT/CAFF2004PWSecured.pdf. [Accessed 2004 August 3]

  72. National Heart, Lung, and Blood Institute. Fact book fiscal year 2002 [online]. Available from URL: http://www.nhlbi.nih.gov/about/02factbk.pdf. [Accessed 2003 Oct]

  73. Cancer screening offered by worksites: United States, 1992 and 1995. MMWR Morb Mortal Wkly Rep 1997; 46: 421–4

  74. Cornfeld MJ, Schnoll RA, Tofani SH, et al. Implementation of a comprehensive cancer control program at the worksite: year one summary report. J Occup Environ Med 2002; 44: 398–406

    Article  PubMed  CAS  Google Scholar 

  75. US Department of Health and Human Services. Healthy People 2010 [online]. Available from URL: http://www.healthypeople.gov/document/tableofcontents.htm [Accessed 2003 Jun 16]

  76. Griffiths RI, McGrath MM, Vogel VG. Economic savings and costs of periodic mammographic screening in the workplace. Oncology 1996; 10: 285–9

    PubMed  CAS  Google Scholar 

  77. Caplin LS, Coughlin SS. Worksite breast cancer screening programs. AAOHN J 1998; 46: 443–51

    Google Scholar 

  78. Lee CH. Screening mammography: proven benefit, continued controversy. Radiol Clin North Am 2002; 40: 395–407

    Article  PubMed  Google Scholar 

  79. Allen JD, Stoddard AM, Mays J, et al. Promoting breast and cervical cancer screening at the workplace: results from the Woman to Woman study. Am J Public Health 2001; 91: 584–90

    Article  PubMed  CAS  Google Scholar 

  80. Reynolds HE, Larkin GN, Jackson VP, et al. Fixed-facility workplace screening mammography. Am J Roentgenol 1997; 168: 507–10

    CAS  Google Scholar 

  81. Burton W, Hoy D. The economic benefit of a corporate-sponsored mammography program. AWHP’s Worksite Health 1996 Summer; 3(2): 27–33

    Google Scholar 

  82. Schrammel P, Griffiths RI, Griffiths DB. A workplace breast cancer screening program. AAOHN J 1998; 46: 523–9

    PubMed  CAS  Google Scholar 

  83. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000; 133: 573–84

    PubMed  CAS  Google Scholar 

  84. Tilley BC, Vernon SW, Myers R, et al. The Next Step Trial: impact of a worksite colorectal cancer screening promotion program. Prev Med 1999; 28: 276–83

    Article  PubMed  CAS  Google Scholar 

  85. Sandeep V, Hwang EW, Hofer TP, et al. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 2001; 111: 593–601

    Article  Google Scholar 

  86. Coughlin SS, Caplan LS, Lawson HW. Cervical cancer screening in the workplace. AAOHN J 2002, 39

  87. Snyder C, Schrammel PN, Griffiths CB, et al. Prostate cancer screening in the workplace. AAOHN J 1998; 46: 379–84

    PubMed  CAS  Google Scholar 

  88. Kantrowitz W, Doyle J, Semeraro J, et al. Prostate cancer screening in a large corporation population. J Occup Environ Med 1995; 37: 1193–8

    Article  PubMed  CAS  Google Scholar 

  89. Kurtz ME, Given B, Given CW, et al. Relationships of barriers and facilitators to breast self-examination, mammography, and clinical breast examination in a worksite population. Cancer Nurs 1993; 16: 251–9

    PubMed  CAS  Google Scholar 

  90. Myers RE, Vernon SW, Carpenter AV, et al. Employee response to a companysponsored program of colorectal and prostate cancer screening. Cancer Detect Prev 1997; 21: 380–9

    PubMed  CAS  Google Scholar 

  91. Musich S, McDonald T, Hirschland D, et al. Self-reported utilization of preventive health services among active employees 55 to 64 years. AWHP’s Worksite Health 2001; 8: 28–35

    Google Scholar 

  92. Powell-Griner E, Boen J, Bland S. Healthcare coverage and use of preventive services among the near elderly in the United States. Am J Public Health 1999; 89: 882–6

    Article  PubMed  CAS  Google Scholar 

  93. Paskett ED, Masten KB, Phillips KC, et al. Receptivity of a worksite breast cancer screening education program. Health Educ Res 1999; 14: 667–74

    Article  PubMed  CAS  Google Scholar 

  94. Mayer JA, Jones JA, Eckhardt LE, et al. Evaluation of a worksite mammography program. Am J Prev Med 1993; 9: 244–9

    PubMed  CAS  Google Scholar 

  95. Thomas B, Stamler LL, Lafreniere KD, et al. Breast health educational interventions. AAOHN J 2002; 50: 460–7

    PubMed  Google Scholar 

  96. Linnan LA, Emmons KM, Klar N, et al. Challenges to improving the impact of worksite cancer prevention programs: comparing reach, enrollment, and attrition using active versus passive recruitment strategies. Ann Behav Med 2002; 24: 157–66

    Article  PubMed  Google Scholar 

  97. Hope A, Kelleher C, O’Connor M. Lifestyle and cancer: the relative effects of a workplace health promotion program across gender and social class. Am J Health Promot 1999; 13: 315–8

    Article  PubMed  CAS  Google Scholar 

  98. Sorensen G, Stoddard AM, LaMontagne AD, et al. A comprehensive worksite cancer prevention intervention: behavior change results from a randomized control trial (United States). Cancer Causes Control 2002; 13: 493–502

    Article  PubMed  Google Scholar 

  99. National Institute of Mental Health. The numbers count: mental disorders in America 2001 [online]. Available from URL: http://www.nimh.gov/publicat/numbers.cfm. [Accessed 2004 Aug 3]

  100. Goetzel RZ, Ozminkowski RJ, Sederer LI, et al. The business case for quality mental health services: why employers should care about the mental health and well-being of their employees. J Occup Environ Med 2002; 44: 320–30

    Article  PubMed  Google Scholar 

  101. Druss BG, Rosenheck RA, Sledge WH. Health and disability costs of depressive illness in a major corporation. Am J Psychiatry 2000; 157: 1274–8

    Article  PubMed  CAS  Google Scholar 

  102. Conti DJ, Burton WN. The economic impact of depression in a workplace. J Occup Med 1994; 36: 983–8

    PubMed  CAS  Google Scholar 

  103. Claxton AJ, Chawla AJ, et al. Absenteeism among employees treated for depression. J Occup Environ Med 1999; 41: 605–11

    Article  PubMed  CAS  Google Scholar 

  104. Dewa CS, Goering P, Lin E, et al. Depression-related short-term disability in an employed population. J Occup Environ Med 2002; 44: 628–33

    Article  PubMed  Google Scholar 

  105. Kessler RC, Barber C, Birnbaum HG, et al. Depression in the workplace: effects on short-term disability. Health Aff 1999; 18: 163–71

    Article  CAS  Google Scholar 

  106. Broadhead WE, Blazer DG, George LK, et al. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 1990; 264: 2524–8

    Article  PubMed  CAS  Google Scholar 

  107. Williams RA, Strasser PB. Depression in the workplace. Impact on employees. AAOHN J 1999; 47: 526–37

    PubMed  CAS  Google Scholar 

  108. Nease DE, Malouin JM. Depression screening: a practical strategy. J Fam Pract 2003; 52: 118–24

    PubMed  Google Scholar 

  109. Whooley MA, Avins Al, Miranda J, et al. Case-finding instruments for depression. J Gen Intern Med 1997; 12: 429–45

    Article  Google Scholar 

  110. Pignone MP, Baynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002; 136: 765–76

    PubMed  Google Scholar 

  111. Valenstein M, Vijan S, Zeber JE, et al. The cost-utility of screening for depression in primary care. Ann Intern Med 2001; 134: 345–59

    PubMed  CAS  Google Scholar 

  112. Riotto M. Depression in the workplace: negative effects, perspective on drug costs and benefit solutions. Benefits Q 2001; 17: 37–48

    PubMed  CAS  Google Scholar 

  113. Zarkin GA, Bray JW, Qi J. The effect of employee assistance programs use on healthcare utilization. Health Serv Res 2000; 35: 77–100

    PubMed  CAS  Google Scholar 

  114. Von Korff M, Katon W, Bush T, et al. Treatment costs, cost offset, and costeffectiveness of collaborative management of depression. Psychosom Med 1998; 60: 143–9

    Google Scholar 

  115. Simon GE, Manning WG, Katzelnick DJ, et al. Cost-effectiveness of systematic depression treatment for high utilizers of general medical care. Arch Gen Psychiatry 2001; 58: 181–7

    Article  PubMed  CAS  Google Scholar 

  116. Simon GE, Van Korff M, Ludman EJ, et al. Cost-effectiveness of a program to prevent depression relapse in primary care. Med Care 2002; 40: 941–50

    Article  PubMed  Google Scholar 

  117. Simon GE, Van Korff M, Rutter C, et al. Randomised trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. BMJ 2000; 320: 550–4

    Article  PubMed  CAS  Google Scholar 

  118. Berndt ER, Finkelstein SN, Greenberg PE, et al. Workplace performance effects from chronic depression and its treatment. J Health Econ 1998; 17: 511–35

    Article  PubMed  CAS  Google Scholar 

  119. Simon GE, Revicki D, Heiligenstein J, et al. Recovery from depression, work productivity, and health care costs among primary care patients. Gen Hosp Psychiatry 2000; 22: 153–62

    Article  PubMed  CAS  Google Scholar 

  120. Schoenbaum M, Unutzer J, Sherbourne C, et al. Cost-effectiveness of practiceinitiated quality improvement for depression. JAMA 2001; 286: 1325–30

    Article  PubMed  CAS  Google Scholar 

  121. Lin EHB, Katon WJ, Simon GE, et al. Low-intensity treatment of depression in primary care: is it problematic? Gen Hosp Psychiatry 2000; 22: 78–83

    Article  PubMed  CAS  Google Scholar 

  122. Rosenheck RA, Druss BG, Stolar M, et al. Effect of declining mental health service use on employees of a large corporation. Health Aff 1999; 18: 193–203

    Article  CAS  Google Scholar 

  123. Wollersheim JP. Depression, women and the workplace. Occup Med 1993; 8: 787–95

    PubMed  CAS  Google Scholar 

  124. Dunnagan T, Peterson M, Haynes G. Mental health issues in the workplace: a case for a new managerial approach. J Occup Environ Med 2001; 43: 1073–80

    PubMed  CAS  Google Scholar 

  125. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003; 26: 917–32

    Article  Google Scholar 

  126. Killilea T. Long-term consequences of type 2 diabetes mellitus: economic impact on society and managed care. Am J Manag Care 2002; 8: S441–9

    PubMed  Google Scholar 

  127. Rubin RH, Altman WM, Mendelson DN. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 1994; 78: 809A–F

    Article  PubMed  CAS  Google Scholar 

  128. Burton WN, Conti DH. Use of an integrated health data management warehouse to measure the employer costs of five chronic disease states. J Dis Manage 1998; 1: 17–26

    Article  Google Scholar 

  129. Benjamin SM, Rolka DB, Valdez R, et al. Estimated number of adults with prediabetes in the US in 2000. Diabetes Care 2003; 26: 645–9

    Article  PubMed  Google Scholar 

  130. American Diabetes Association: Pre-diabetes [online]. Available from URL: http://www.diabetes.org/main/info/pre-diabetes.jsp. [Accessed 2003 Jun 16]

  131. Harris MI, Eastman RC. Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev 2000; 16: 230–6

    Article  PubMed  CAS  Google Scholar 

  132. Harris R, Donahue K, Rathore SS, et al. Screening adults for type 2 diabetes: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2003; 138: 215–34

    PubMed  Google Scholar 

  133. Tuomilehto J, Lindstrom J, Eriksson J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–50

    Article  PubMed  CAS  Google Scholar 

  134. Lindstrom J, Tuomilehto J. The diabetes risk score. Diabetes Care 2003; 26: 725–31

    Article  PubMed  Google Scholar 

  135. Spijkerman AMW, Stehouwer CDA, Adriaanse MC, et al. Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care 2002; 25: 1784–9

    Article  PubMed  Google Scholar 

  136. Steffens B. Cost-effective management of type 2 diabetes: providing quality care in a cost-constrained environment. Am J Manag Care 2000; 6: S697–703

    PubMed  CAS  Google Scholar 

  137. Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383–93

    Article  PubMed  Google Scholar 

  138. Wagner EH, Sandhu N, Newton KM, et al. Effect of improved glycemic control on health care costs and utilization. JAMA 2001; 285: 182–9

    Article  PubMed  CAS  Google Scholar 

  139. Burton WN, Connerty CM. Evaluation of a worksite-base patient education intervention targeted at employees with diabetes mellitus. J Occup Environ Med 1998; 40: 702–6

    Article  PubMed  CAS  Google Scholar 

  140. Raji A, Gomes H, Beard JO, et al. A randomized trial comparing intensive and passive education in patients with diabetes mellitus. Arch Intern Med 2002; 162: 1301–4

    Article  PubMed  Google Scholar 

  141. Norris SL, Schmid CH, Lau J, et al. Self-management education for adults with Type 2 diabetes. Diabetes Care 2002; 25: 1159–71

    Article  PubMed  Google Scholar 

  142. Lacey KO, Chyun DA, Grey M. An integrative literature review of cardiac risk factor management in diabetes education interventions. Diabetes Educ 2000; 26: 812–20

    Article  PubMed  CAS  Google Scholar 

  143. Sidorov J, Girolami S, Shull R, et al. Does diabetes disease management save money and improve outcomes? Diabetes Care 2002; 25: 684–9

    Article  PubMed  Google Scholar 

  144. Berger J, Slezak J, Stine N, et al. Economic impact of a diabetes disease management program in a self-insured health plan: early results. Dis Manag 2001; 4: 65–73

    Article  Google Scholar 

  145. Rubin RJ, Dietrich KA, Hawk AD. Clinical and economic impact of implementing a comprehensive diabetes management program in managed care. J Clin Endocrinol Metab 1998; 83: 2635–42

    Article  PubMed  CAS  Google Scholar 

  146. Ibrahim IA, Beich J, Sidorov J, et al. Measuring outcomes of type 2 diabetes disease management program in an HMO setting. South Med J 2002; 95: 78–87

    PubMed  Google Scholar 

  147. Berg GD, Wadhwa S. Diabetes disease management in a community-based setting. Manag Care 2002; 11: 42, 45–50

    PubMed  Google Scholar 

  148. Strategies for reducing morbidity and mortality from diabetes through health-care system interventions and diabetes self-management in community settings. MMWR Morb Mortal Wkly Rep 2001; 50: 1–15

  149. Burton WN, Connerty CM. Worksite-based diabetes disease management program. Dis Manag 2002; 5: 1–8

    Article  Google Scholar 

  150. The CDC Centers for Disease ControlDiabetes Cost-Effectiveness Group. Costeffectiveness of intensive glycemic control, intensified hypertension control and serum cholesterol level reduction for type 2 diabetes. JAMA 2002; 287: 2542–51

    Article  Google Scholar 

  151. Gray A, Raikou M, McGuire A, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomized controlled trial. BMJ 2000; 320: 1373–8

    Article  PubMed  CAS  Google Scholar 

  152. Glasgow RE, Toobert DJ, Hampson SE, et al. Implementation, generalization and long-term results of the “choosing well diabetes self-management intervention. The CDC Centers for Disease Control Diabetes Cost-Effectiveness Group. Patient Educ Couns 2002; 48: 115–22

    Article  PubMed  Google Scholar 

  153. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases. The prevention or delay of type 2 diabetes. Diabetes Care 2002; 25: 742–9

    Article  Google Scholar 

  154. Hamdy O, Goodyear LJ, Horton ES. Diet and exercise in type 2 diabetes mellitus. Endocrinol Metab Clin North Am 2001; 30: 883–907

    Article  PubMed  CAS  Google Scholar 

  155. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–50

    Article  PubMed  CAS  Google Scholar 

  156. Nelson KM, Reiber G, Boyko EJ. Diet and exercise among adults with type 2 diabetes. Diabetes Care 2002; 10: 1722–8

    Article  Google Scholar 

  157. American Heart Association. Heart disease and stroke statistics: 2004 update. Dallas (TX): American Heart Association, 2003

    Google Scholar 

  158. Stampfer MJ, Hu FB, Manson JE, et al. Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med 2000; 343: 16–22

    Article  PubMed  CAS  Google Scholar 

  159. US Department of Health and Human Services. Healthy People 2010 [online]. Available from URL: http://www.healthypeople.gov/document/tableofcontents.htm [Accessed 2003 Jun 16]

  160. Brown AID, Garber AM. Risk factor modification for cardiac disease: a concise review of the cost-effectiveness of coronary heart disease prevention. Med Clin North Am 2000; 84: 279–97

    Article  PubMed  CAS  Google Scholar 

  161. Ashaya MO, Giles WH. Are heart disease patients more likely to have healthy lifestyle behaviors? Results from the 2000 Behavioral Risk Factor Surveillance Survey. J Cardiovasc Risk 2003; 10: 207–12

    Article  Google Scholar 

  162. Capriotti T, Kirby LG, Smeltzer SC. Unrecognized high blood pressure. AAOHN J 2000; 48: 338–43

    PubMed  CAS  Google Scholar 

  163. Getliffe KA, Crouch R, Gage H, et al. Hypertension awareness, detection and treatment in a university setting: results of a worksite screening. Public Health 2000; 114: 361–6

    PubMed  CAS  Google Scholar 

  164. Erfurt JC, Foote A, Heirich MA. The cost-effectiveness of work-site Wellness programs for hypertension control, weight loss, and smoking cessation. J Occup Med 1991; 33: 962–70

    Article  PubMed  CAS  Google Scholar 

  165. Foote A, Erfurt JC. The benefit to cost ratio of work-site blood pressure control programs. JAMA 1991; 265: 1283–6

    Article  PubMed  CAS  Google Scholar 

  166. Wang JS, Carson EC, Lapane KL, et al. The effect of physician office visits on CHD risk factor modification as part of a worksite cholesterol screening program. Prev Med 1999; 28: 221–8

    Article  PubMed  CAS  Google Scholar 

  167. Aldana SG, Greenlaw R, Diehl HA, et al. Impact of the Coronary Health Improvement Project (CHIP) on several employee populations. J Occup Environ Med 2002; 44: 831–9

    Article  PubMed  Google Scholar 

  168. Stein EA. Identification and treatment of individuals at high risk of coronary heart disease. Am J Med 2002; 112: 3S–9S

    Article  PubMed  Google Scholar 

  169. Fox J, Jones K. Lipid-lowering interventions in managed care settings. Am J Med 2001; 110: 24S–30S

    Article  PubMed  Google Scholar 

  170. Crouch MA. Effective use of statins to prevent coronary heart disease. Am Fam Physician 2000; 63: 309–20

    Google Scholar 

  171. Wilson MG, Edmunson J, DeJoy DM. Cost effectiveness of work-site cholesterol screening and intervention programs. J Occup Med 1992; 34: 642–9

    PubMed  CAS  Google Scholar 

  172. Duffy CP. Worksite cholesterol screening and diet education programs. AAOHN J 1998; 46: 147–53

    PubMed  CAS  Google Scholar 

  173. Guico-Pabia CJ, Cioffi L, Shoner LG. The Lucent-Takes-Heart cardiovascular health management program. AAOHN J 2002; 50: 365–72

    PubMed  Google Scholar 

  174. Nilsson PM, Klasson EB, Nyberg P. Life-style intervention at the worksite: reduction of cardiovascular risk factors in a randomized study. Scand J Work Environ Health 2001; 27: 57–62

    Article  PubMed  CAS  Google Scholar 

  175. Gomel MK, Oldenburg B, Simpson JM, et al. Composite cardiovascular risk outcomes of a work-site intervention trial. Am J Public Health 1997; 87: 673–6

    Article  PubMed  CAS  Google Scholar 

  176. Byers T, Mullis R, Anderson J, et al. The costs and effects of a nutritional education program following work-site cholesterol screening. Am J Public Health 1995; 85: 650–5

    Article  PubMed  CAS  Google Scholar 

  177. Glasgow RE, Terborg JR, Strycker LA, et al. Take Heart II: replication of a worksite health promotion trial. J Behav Med 1997; 20: 143–61

    Article  PubMed  CAS  Google Scholar 

  178. Angotti CM, Chan WT, Sample CJ, et al. Combined dietary and exercise intervention for control of serum cholesterol in the workplace. Am J Health Promot 2000; 15: 9–16

    Article  PubMed  CAS  Google Scholar 

  179. Wasserman J, Whitmer RW, Bazzarre TL, et al. Gender-specific effects of modifiable health risk factors on coronary heart disease and related expenditures. J Occup Environ Med 2000; 42: 1060–9

    Article  PubMed  CAS  Google Scholar 

  180. Anderson J, Dusenbury L. Worksite cholesterol and nutrition. AAOHN J 1999; 47: 99–106

    PubMed  CAS  Google Scholar 

  181. Tanasescu M, Leitzmann MF, Rimm EB, et al. Exercise type and intensity in relation to coronary heart disease in men. JAMA 2002; 288: 1994–2000

    Article  PubMed  Google Scholar 

  182. Manson JE, Hu FB, Rich-Edward JW, et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 1999; 341: 650–8

    Article  PubMed  CAS  Google Scholar 

  183. Wannamethee SG, Shaper AG, Walker M, et al. Lifestyle and 15-year survival of heart attack, stroke and diabetes in middle-aged British men. Arch Intern Med 1998; 158: 2433–40

    Article  PubMed  CAS  Google Scholar 

  184. Smith SC. Risk reduction therapies for patients with coronary artery disease: a call for increased implementation. Am J Med 1998; 104: 23S–6S

    Article  PubMed  Google Scholar 

  185. Gaspoz JM, Coxson PG, Goldman PA, et al. Cost effectiveness of aspirin, clorpidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med 2002; 346: 1800–6

    Article  PubMed  Google Scholar 

  186. Lipton RB, Silberstein SD, Burton WN. Relieving an employer’s economic headache: ten action steps for managing migraine in the workplace. Am J Integrat Healthcare 1997; 1: 26–31

    Google Scholar 

  187. Warshaw LJ, Burton WN, Schneider WJ. Role of the workplace in migraine disease management. Dis Manag Health Outcomes 2001; 9: 99–115

    Article  Google Scholar 

  188. Warshaw LJ, Burton WN. Cutting the costs of migraine: role of the employee health unit. J Occup Environ Med 1998; 40: 943–53

    Article  PubMed  CAS  Google Scholar 

  189. Gallagher RM, Cutrer FM. Migraine: diagnosis, management, and new treatment options. Am J Manag Care 2002; 8(3 Suppl.): S58–SS73

    PubMed  Google Scholar 

  190. Hu XH, Markson LE, Lipton RB, et al. Burden of migraine in the United States. Arch Intern Med 1999; 159: 813–8

    Article  PubMed  CAS  Google Scholar 

  191. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort. Neurology 1999; 53: 537–42

    Article  PubMed  CAS  Google Scholar 

  192. Burton WN, Conti DJ, Chen CY, et al. The economic burden of lost productivity due to migraine headache: a specific worksite analysis. J Occup Environ Med 2002, 529

  193. Fishman P, Black L. Indirect costs of migraine in a managed care. Cephalalgia 1999; 19: 50–7

    Article  PubMed  CAS  Google Scholar 

  194. Taking a disease management approach to migraine: based on a presentation by William Parham III, MD. Am J Manag Care 1999; 5: A104–10

  195. Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med 1997; 39: 320–7

    Article  PubMed  CAS  Google Scholar 

  196. Gervil M, Ulrich V, Olesen J, et al. Screening for migraine in the general population: validation of a simple questionnaire. Cephalalgia 1998; 18: 342–8

    Article  PubMed  CAS  Google Scholar 

  197. Pop PHM, Gierveid CM, Karis HAM, et al. Epidemiological aspects of headache in a workplace setting and the impact on the economic loss. Eur J Neurol 2002; 9: 171–4

    Article  PubMed  CAS  Google Scholar 

  198. Lipton RB, Scher AI, Kolodner K, et al. Migraine in the United States: epidemiology and patterns of health care use. Neurology 2002; 58: 885–94

    Article  PubMed  CAS  Google Scholar 

  199. Rapoport AM, Adelman JU. Cost of migraine management: a pharmacoeconomic overview. Am J Manag Care 1998; 4: 531–45

    PubMed  CAS  Google Scholar 

  200. Warshaw LJ, Burton WN, Silberstein SD, et al. Migraine: a problem for employers and managed care plans. Am J Manag Care 1997; 3: 1515–23

    PubMed  CAS  Google Scholar 

  201. Loeppke R, Hymel PA, Lofland JH, et al. Health-related workplace productivity measurement: general and migraine-specific recommendations from the ACOEM expert panel. J Occup Environ Med 2003; 45: 349–59

    Article  PubMed  Google Scholar 

  202. Lerner DJ, Amick BC, Malspeis S, et al. The migraine work and productivity loss questionnaire: concepts and design. Qual Life Res 1999; 8: 699–710

    Article  PubMed  CAS  Google Scholar 

  203. Schneider WJ, Furth P, Blalock TH, et al. A pilot study of a headache program in the workplace: the effect of education. J Occup Environ Med 1999; 41: 202–9

    Article  PubMed  CAS  Google Scholar 

  204. Mannix LK, Solomon GD, Kippes CM, et al. Impact of headache education program in the workplace. Neurology 1999; 53: 868–71

    Article  PubMed  CAS  Google Scholar 

  205. Cady RC, Ryan R, Jhingran P, et al. Sumatriptan injection reduces productivity loss during a migraine attack. Arch Intern Med 1998; 158: 1013–8

    Article  PubMed  CAS  Google Scholar 

  206. Lofland JH, Kim SS, Batenhorst AS, et al. Cost-effectiveness and cost-benefit of Sumatriptan in patients with migraine. Mayo Clin Proc 2001; 76: 1093–101

    Article  PubMed  CAS  Google Scholar 

  207. Mayo KW, Osterhaus JT. Health outcomes evaluations: estimating the impact of almotriptan in managed care settings. Am J Manag Care 2002; 8(3 Suppl.): S85–93

    PubMed  Google Scholar 

  208. Fries JF, Carey C, McShane DJ. Patient education in arthritis: randomized controlled trial of a mail-delivered program. J Rheumatol 1997; 24(7): 1378–83

    PubMed  CAS  Google Scholar 

  209. Bolton MB, Tilley BC, Kuder J, et al. The cost and effectiveness of an education program for adults who have asthma. J Gen Intern Med 1991; 6: 401–7

    Article  PubMed  CAS  Google Scholar 

  210. Henritze J, Brammell HL. Phase II cardiac Wellness at the Adolph Coors company. Am J Health Promot 1989; 4(1): 25–31

    Article  PubMed  CAS  Google Scholar 

  211. Martin LM, Leff M, Calonge N, et al. Validation of self-reported chronic conditiona and health services in a managed care population. Am J Prev Med 2000; 18: 215–8

    Article  PubMed  CAS  Google Scholar 

  212. Lewis A. Disease management for employers: a primer. Emp Ben Plan Rev 1998; 52(10): 44–5

    Google Scholar 

  213. Fletcher L. Disease management generating savings. Bus Insur 2000; 34(31): 3, 10

    Google Scholar 

Download references

Acknowledgments

The authors received no funding for the preparation of this manuscript and have no conflicts of interest directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Health Management Research Center, University of Michigan, 1027 E. Huron Street, Ann Arbor, Michigan, MI 48104-1688, USA

    Shirley A. Musich (Senior Data Analyst), Alyssa B. Schultz & Dee W. Edington

  2. Bank One, Northwestern University Medical School, Chicago, Illinois, USA

    Wayne N. Burton

Authors
  1. Shirley A. Musich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alyssa B. Schultz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wayne N. Burton
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dee W. Edington
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shirley A. Musich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Musich, S.A., Schultz, A.B., Burton, W.N. et al. Overview of Disease Management Approaches. Dis-Manage-Health-Outcomes 12, 299–326 (2004). https://doi.org/10.2165/00115677-200412050-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200412050-00003

Keywords

Search

Navigation